Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.2K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

854
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
854
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

1.3K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.3K
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

712
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
712
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

962
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
962
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

531
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

The American journal of gastroenterology·2017
Same author

[Risk-benefit of anti-reflux therapy in the premature infant].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015
Same author

Association of N-acetylcysteine and glucagon during percutaneous cholangiography in the treatment of inspissated bile syndrome.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015
Same author

[Let's stop proton pump inhibitor prescriptions for suspected GERD in non-validated indications!].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

[Symptoms of Celiac disease in childhood].

Pathologie-biologie·2011
Same author

[Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2010

Related Experiment Video

Updated: Mar 22, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

1.1K

[Constipation in infants and children: How should it be treated?].

O Mouterde1

  • 1Unité de gastro-entérologie pédiatrique, hôpital Charles-Nicolle, département de pédiatrie, CHU de Rouen, université de Sherbrooke, 1, rue de Germont, 76031 Rouen cedex, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|April 28, 2016
PubMed
Summary

Effective pediatric constipation treatment involves long-term medication like lactulose or polyethylene glycol (PEG) and addressing fecal impaction. Education on toilet habits and psychological support are crucial for sustained recovery.

More Related Videos

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

3.2K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

2.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

1.1K
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

3.2K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

2.1K

Area of Science:

  • Pediatric Gastroenterology
  • Digestive Health
  • Clinical Pediatrics

Background:

  • Functional constipation is a prevalent pediatric issue, often leading to delayed treatment and significant psychosocial and digestive complications.
  • Current management strategies for pediatric constipation require clear, codified, and effective approaches to mitigate long-term effects.

Purpose of the Study:

  • To outline effective, evidence-based treatment protocols for functional constipation in children.
  • To differentiate appropriate therapeutic options based on age and severity, including fecal impaction.

Main Methods:

  • Review of established treatment guidelines for pediatric functional constipation.
  • Analysis of age-specific medication efficacy, including lactulose, lactitol, and polyethylene glycol (PEG).
  • Emphasis on the importance of fecal disimpaction, toilet training, and psychological support.

Main Results:

  • Lactulose/lactitol are effective before 6 months; polyethylene glycol (PEG) is indicated for infants over 6 months.
  • Sufficient dosage and prolonged treatment duration are critical for managing established constipation.
  • Fecal disimpaction using high-dose PEG or phosphate enemas is the primary step for impaction cases.

Conclusions:

  • Established pediatric constipation requires sustained treatment with age-appropriate medications like PEG.
  • Comprehensive management includes fecal disimpaction, toilet habit education, and psychological support to prevent relapse.
  • Hyperosmotic mineral water, diet, and endoanal medications are not primary treatments for established constipation.